109 Division OF Hem/Onc: Oncology Board Review Conference "Immunotherapy" (021623)

Dallas, TX US
February 16, 2023
Course summary
Available credit: 
  • 1.00 AMA
  • 1.00 Attendance
Course opens: 
02/16/2023
Course expires: 
02/16/2023
Event starts: 
02/16/2023 - 7:30am CST
Event ends: 
02/16/2023 - 8:30am CST
Cost:
$0.00
Part of: 
109 DIVISION OF HEM/ONC: ONCOLOGY BOARD REVIEW CONFERENCE 2023
Add to calendar: 
UT Southwestern Medical Center
5323 Harry Hines Blvd.
Dallas, TX 75390
United States
Committee member(s)

Monika Kumar, MD

has no relevant financial relationships to disclose at this time.
Course Director(s)

Amy Jones, M.D.

has no relevant financial relationships to disclose at this time.
Speaker(s)

Heather McArthur, Heather McArthur, MD, MPH

has a financial relationship (Independent contractor) with AstraZeneca;.
has a financial relationship (Independent contractor) with Immunomedics;.
has a financial relationship (Independent contractor) with Crown Bioscience;.
has a financial relationship (Independent contractor) with Pfizer;.
has a financial relationship (Independent contractor) with Daiichi-Sankyo;.
has a financial relationship (Independent contractor) with Gilead;.
has a financial relationship (Independent contractor) with Lilly;.
has a financial relationship (Independent contractor) with Seattle Genetics;.
has a financial relationship (Independent contractor) with Puma Biotechnology;.
has a financial relationship (Independent contractor) with Merck;.

Available Credit

  • 1.00 AMA
  • 1.00 Attendance

Price

Cost:
$0.00
Please login or create an account to take this course.